Orthopaedic oncology refers to the diagnosis and treatment of primary benign and malignant tumors of the bones and soft tissues. Orthopaedic oncology tumors include Ewing sarcoma, osteosarcoma, and other malignancies which involve the musculoskeletal system. Orthopaedic oncology represents a very small share in othropaedic. Orthopaedic oncology treatment includes surgery, chemotherapy, radiation therapy and targeted therapy.
Global orthopaedic oncology market is expected to grow at a significant CAGR during the forecast period i.e. 2017-2024. Factors such as rising prevalence of cancer and strong growth in healthcare sector in developing nations are anticipated to foster the growth of the global orthopaedic oncology market during the forecast period. Moreover, new products and development of advanced treatment methods is expected to bolster the sales of the orthopaedic oncology products.
In the regional market, North America is anticipated to dominate the overall market of orthopaedic oncology during the forecast period. High prevalence of cancer and rapid ageing geriatric population is expected to benefit the growth of orthopaedic oncology market. Apart from this, increasing spending on healthcare and high awareness is anticipated to impel the growth of the orthopaedic oncology market over the forecast period. Europe orthopaedic oncology market is expected to witness substantial growth over the forecast period. Rising penetration of cancer and musculoskeletal related disorders signals promising growth for orthopaedic oncology market in the region. Further, precision oncology is gaining momentum in gaining momentum in European countries and is anticipated to benefit the growth of the orthopaedic oncology market in the years ahead.
Moreover, Asia Pacific ranks as the fastest growing region in orthopaedic oncology market. Growing healthcare infrastructure and rise in the spending on medical treatment is predicted to trigger the growth of the orthopaedic oncology market in the next few years. Countries such as China, Japan, South Korea and India are witnessing augmented demand for orthopaedic oncology products.CLICK TO DOWNLOAD FREE SAMPLE
Based on treatment, orthopaedic oncology market is segmented into surgery, chemotherapy, radiation therapy and targeted therapy, out of which, surgery segment is expected to dominate the overall orthopaedic oncology market during the forecast period.
Our-in depth analysis of the global orthopaedic oncology market includes the following segments:
The global orthopaedic oncology market is further classified on the basis of region as follows:
Increasing prevalence of musculoskeletal oncology is the major factor which is expected to intensify the growth of the orthopaedic oncology market. Further, rapid growth in ageing population in various developed nations is anticipated to positively impact the demand for orthopaedic oncology treatment during the forecast period. Apart from this, high growth in the number of new cases diagnosed in the past few years is expected to trigger the growth rate of global orthopaedic oncology market. Increasing healthcare expenditure and rising per capita income of the population is anticipated to positively impact the growth of the global orthopaedic oncology market.
Favorable government initiatives and policies to limit the number of deaths from musculoskeletal cancer are anticipated to foster the growth of the global orthopaedic oncology market during the forecast period. Furthermore, rising number of multispecialty and cancer hospitals across the globe are envisioned to bolster the growth of global orthopaedic oncology market.
The market stands to benefit from increasing number of research and development activities. Moreover, development of precision oncology is offering profitable opportunities for the growth of the global orthopaedic oncology market.
However, costly and complicated treatment therapies are a major stumbling block for the growth of orthopaedic oncology market. Lack of awareness about bone and musculoskeletal malignancies among the population is anticipated to negatively impact the growth of the global orthopaedic oncology market. Moreover, strict approval regulations are also slowing down the growth of orthopaedic oncology market.
Overview of the Parent Market
The global orthopaedic oncology market is segmented as follows:
Supply & Demand Risk
Porter’s Five Force Model
Geographical Economic Activity
Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio
Recent Trends and Developments
Industry Growth Drivers and Challenges
Key Information for Players to establish themselves in current dynamic environment
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization